Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-03-011164
Filing Date
2003-09-29
Accepted
2003-09-29 17:21:55
Documents
8
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 VIAGREN, INC. g85078e10vk.htm 10-K 1175246
3 SUBSIDIARIES g85078exv21w1.htm EX-21.1 10723
4 CONSENT OF CERTIFIED PUBLIC ACCOUNTANTS g85078exv23w1.htm EX-23.1 2266
5 CERTIFICATION PURSUANT TO SECTION 302- CEO g85078exv31w1.htm EX-31.1 5720
6 CERTIFICATION PURSUANT TO SECTION 302- CFO g85078exv31w2.htm EX-31.2 5711
7 CERTIFICATION PURSUANT TO SECTION 906- CEO g85078exv32w1.htm EX-32.1 3885
8 CERTIFICATION PURSUANT TO SECTION 906- CFO g85078exv32w2.htm EX-32.2 3876
9 GRAPHIC g85078g8507800.gif GRAPHIC 8916
  Complete submission text file 0000950144-03-011164.txt   1218834
Mailing Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324
Business Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324 9542338746
VIRAGEN INC (Filer) CIK: 0000353482 (see all company filings)

EIN.: 592101668 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-15823 | Film No.: 03915745
SIC: 2836 Biological Products, (No Diagnostic Substances)